Terms: = Leukemia AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Clinical Outcome
11 results:
1. Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.
Zhang C; Stelloo E; Barrans S; Cucco F; Jiang D; Tzioni MM; Chen Z; Li Y; Swennenhuis JF; Makker J; Rásó-Barnett L; Liu H; El-Daly H; Soilleux E; Shah N; Nagumantry SK; Kyaw M; Prahladan MP; Tooze R; Westhead DR; Feitsma H; Davies AJ; Burton C; Johnson PWM; Du MQ
Leukemia; 2024 Mar; 38(3):621-629. PubMed ID: 38184753
[TBL] [Abstract] [Full Text] [Related]
2. The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research.
Coupland SE; Du MQ; Ferry JA; de Jong D; Khoury JD; Leoncini L; Naresh KN; Ott G; Siebert R; Xerri L;
J Pathol; 2024 Mar; 262(3):255-270. PubMed ID: 38180354
[TBL] [Abstract] [Full Text] [Related]
3. Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
Bomken S; Enshaei A; Schwalbe EC; Mikulasova A; Dai Y; Zaka M; Fung KTM; Bashton M; Lim H; Jones L; Karataraki N; Winterman E; Ashby C; Attarbaschi A; Bertrand Y; Bradtke J; Buldini B; Burke GAA; Cazzaniga G; Gohring G; De Groot-Kruseman HA; Haferlach C; Nigro LL; Parihar M; Plesa A; Seaford E; Sonneveld E; Strehl S; Van der Velden VHJ; Rand V; Hunger SP; Harrison CJ; Bacon CM; Van Delft FW; Loh ML; Moppett J; Vormoor J; Walker BA; Moorman AV; Russell LJ
Haematologica; 2023 Mar; 108(3):717-731. PubMed ID: 35484682
[TBL] [Abstract] [Full Text] [Related]
4. Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement.
Bill M; Mrózek K; Giacopelli B; Kohlschmidt J; Nicolet D; Papaioannou D; Eisfeld AK; Kolitz JE; Powell BL; Carroll AJ; Stone RM; Garzon R; Byrd JC; Bloomfield CD; Oakes CC
J Hematol Oncol; 2021 Jul; 14(1):107. PubMed ID: 34229733
[TBL] [Abstract] [Full Text] [Related]
5. Cardiac Hematological Malignancies: Typical Growth Patterns, Imaging Features, and clinical outcome.
Voigt P; Wienbeck S; Weber MA; Oyama-Manabe N; Beimler M; Schob S; Kahn T; Meyer HJ; Randaxhe JF; Surov A
Angiology; 2018 Feb; 69(2):170-176. PubMed ID: 28602141
[TBL] [Abstract] [Full Text] [Related]
6. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven bcl6 expression.
Sato T; Tran TH; Peck AR; Girondo MA; Liu C; Goodman CR; Neilson LM; Freydin B; Chervoneva I; Hyslop T; Kovatich AJ; Hooke JA; Shriver CD; Fuchs SY; Rui H
Oncogene; 2014 Apr; 33(17):2215-24. PubMed ID: 23708665
[TBL] [Abstract] [Full Text] [Related]
7. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
Tomita N; Tokunaka M; Nakamura N; Takeuchi K; Koike J; Motomura S; Miyamoto K; Kikuchi A; Hyo R; Yakushijin Y; Masaki Y; Fujii S; Hayashi T; Ishigatsubo Y; Miura I
Haematologica; 2009 Jul; 94(7):935-43. PubMed ID: 19535347
[TBL] [Abstract] [Full Text] [Related]
9. bcl6: somatic mutations and expression in early-stage chronic lymphocytic leukemia.
Jantus Lewintre E; Reinoso Martín C; García Ballesteros C; Pendas J; Benet Campos C; Mayans Ferrer JR; García-Conde J
Leuk Lymphoma; 2009 May; 50(5):773-80. PubMed ID: 19367498
[TBL] [Abstract] [Full Text] [Related]
10. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Simonitsch-Klupp I; Hauser I; Ott G; Drach J; Ackermann J; Kaufmann J; Weltermann A; Greinix HT; Skrabs C; Dittrich C; Lutz D; Pötter R; Mannhalter C; Lechner K; Chott A; Jaeger U
Leukemia; 2004 Jan; 18(1):146-55. PubMed ID: 14603341
[TBL] [Abstract] [Full Text] [Related]
11. The bcl6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene.
Lossos IS; Akasaka T; Martinez-Climent JA; Siebert R; Levy R
Leukemia; 2003 Jul; 17(7):1390-7. PubMed ID: 12835729
[TBL] [Abstract] [Full Text] [Related]
